Stemtech

Stemtech Revenue per Share

The Revenue per Share of Stemtech (STEK) as of Nov 1, 2026 is 0.02 USD. In the previous year, Revenue per Share was 0.04 USD — a change of -43.08% (lower).

Revenue per Share

0.02USD

YoY

-43.08%

Last updated:

Revenue per Share of Stemtech is 2025 0.02 USD. Revenue per Share of Stemtech was 2024 0.04 USD. It decreases by -43.08% lower compared to the previous year.

The Stemtech Revenue per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
Date
Revenue per Share
Jan 1, 2019
0.06 USD
Jan 1, 2020
0.13 USD
Jan 1, 2021
0.10 USD
Jan 1, 2022
0.09 USD
Jan 1, 2023
0.05 USD
Jan 1, 2024
0.04 USD
Jan 1, 2025
0.02 USD
The Stemtech Revenue per Share history
YEARRevenue per ShareYoY
0.02USD-43.08%
0.04USD-7.66%
0.05USD-50.01%
0.09USD-3.04%
0.10USD-22.96%
0.13USD+121.45%
0.06USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Stemtech Stock analysis

What does Stemtech do? Stemtech Corp develops nutritional supplements that support stem cell activity, marketed internationally through subsidiaries and independent distributors. The company's products include the RCM System, stemrelease3, Stemflo MigraStem, OraStem for oral health, and D-Fuze for electromagnetic frequency blocking. Cellect One Rapid Renew Stem Cell Peptide Night Cream is its skincare offering. Products are sold in North America, Latin America, and Asia through distributors and subsidiaries. The firm's brands target health-conscious consumers seeking stem cell support, with OraStem focusing on oral care and D-Fuze addressing electromagnetic frequency concerns. Independent distributors handle sales across all segments, leveraging the company's international presence. The RCM System and stemrelease3 are core products for general stem cell enhancement. Stemtech Corp's revenue streams come from direct sales of its branded nutritional supplements and skincare products. Distributors purchase products from subsidiaries to resell, generating consistent income through these channels. The company's international segments ensure diverse market coverage without relying on a single region. Stemtech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Stemtech stock

Revenue per Share of Stemtech is 0.02 USD in 2025.

Revenue per Share of Stemtech changed from 0.04 USD to 0.02 USD, representing a -43.08% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Revenue per Share Stemtech since 2006 – with annual values, charts, and detailed analysis.

Revenue per Share divides total revenue by shares outstanding, showing how much revenue each share represents.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Stemtech

All Key Metrics — Stemtech